Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy
Pediatric Blood & Cancer · 2023
DOI: 10.1002/pbc.30296 ↗At a glance
Fallbericht in Pediatric Blood & Cancer, 2023. Written by Evan Cantor and 3 co-authors. Institution: Division of Hematology and Oncology, Connecticut Children's Medical Center, Hartford, Connecticut, USA. Major MEDLINE topics: Ganglioglioma, Brain Neoplasms. Cited 2 times so far (Crossref); 8 references. The full text is freely available in PubMed Central. Funded by: NICHD NIH HHS.
Abstract (original language)
To the Editor: Gangliogliomas (GG) are composed ofmixed neuronal and glial components and are commonly associated with neurologic symptoms that vary by tumor location. Biologically targeted agents such as the BRAF inhibitors dabrafenib and vemurafenib are now used to treat progressive low-grade gliomas (LGG), including GG,1,2 but the effect of these agents on the neurologic symptoms that may accompany LGGs is poorly understood.3 Here, we describe clinical and radiographic response from single-therapy BRAF inhibition in two patients with
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Division of Hematology and Oncology, Connecticut Children's Medical Center, Hartford, Connecticut, USA.
- Department of Pediatrics, UCONN School of Medicine, Farmington, Connecticut, USA.
- Departments of Radiology, Children's Mercy Hospital, Kansas City, Missouri, USA.
- Division of Pediatric Oncology, Children's Hospital of Orange County, Orange, California, USA.
- Departments of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
ORCID profiles: Evan Cantor
Funding
- NICHD NIH HHS
Cite
APA
Cantor, E., Berkovich, R., Navalkele, P., & Brossier, N. M. (2023). Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30296
Vancouver
Cantor E, Berkovich R, Navalkele P, Brossier NM. Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30296
BibTeX
@article{Cantor2023,
author = {Cantor, Evan and Berkovich, Rachel and Navalkele, Pournima and Brossier, Nicole M},
title = {Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy},
journal = {Pediatric Blood & Cancer},
year = {2023},
doi = {10.1002/pbc.30296}
}
EUVIMED